First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors

NCT07700160 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: VBC108

Sponsor

VelaVigo Bio Inc